• 1. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 2. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 3. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

(R)-2-Amino-2-phenylacetic acid hydrochloride: A Comprehensive Overview of Its Chemical Structure, Pharmacological Properties, and Research Advances

(R)-2-Amino-2-phenylacetic acid hydrochloride, also known by its CAS No. 25705-52-6, is a chiral compound that has garnered significant attention in the field of biomedical research. This molecule, characterized by its unique chemical structure and functional groups, plays a pivotal role in various pharmacological applications. Recent studies have highlighted its potential in drug development, neurological disorders, and metabolic pathways. Understanding the molecular mechanisms and biological activities of this compound is essential for advancing therapeutic strategies in modern medicine.

The chemical structure of (R)-2-Amino-2-phenylacetic acid hydrochloride consists of a central carbon atom bonded to an amino group, a phenyl ring, and a carboxylic acid group. This stereochemistry is critical for its biological activity, as the R configuration determines its interaction with specific receptors and enzymes. The hydrochloride salt form enhances its solubility and stability, making it suitable for pharmaceutical formulations. Recent advances in computational chemistry have allowed researchers to model its three-dimensional structure and predict its behavior in biological systems.

Pharmacologically, (R)-2-Amino-2-phenylacetic acid hydrochloride exhibits selective agonist activity towards various GPCR (G protein-coupled receptor) families. Studies published in Journal of Medicinal Chemistry (2023) have demonstrated its potential as a modulator of neurotransmitter systems, particularly in the serotonin and <

Recent breakthroughs in drug discovery have positioned (R)-2-Amino-2-phenylacetic acid hydrochloride as a promising candidate for treating neurodegenerative diseases such as Alzheimer's and Parkinson's. A 2024 study in Nature Communications revealed its ability to inhibit β-amyloid aggregation, a key pathological feature of Alzheimer's disease. This finding underscores the compound's potential in targeted therapies for neurological disorders. Additionally, its anti-inflammatory properties have been explored in the context of autoimmune diseases, with preclinical trials showing significant immune modulation effects.

The synthetic methods for producing (R)-2-Amino-2-phenylacetic acid hydrochloride have evolved significantly in recent years. Traditional asymmetric synthesis approaches, such as enantioselective catalysis, have been optimized to achieve high enantiomeric purity. A 2023 paper in Organic Letters introduced a novel enantiocontrolled route that utilizes chiral auxiliaries to enhance the efficiency of the reaction. These advancements not only improve the scalability of production but also reduce environmental impact, aligning with the principles of green chemistry.

From a pharmacokinetic perspective, (R)-2-Amino-2-phenylacetic acid hydrochloride demonstrates favorable absorption, distribution, metabolism, and excretion profiles. Its lipophilicity allows for efficient cell membrane penetration, while its hydrophilic groups facilitate renal excretion. A 2023 study in Drug Metabolism and Disposition highlighted its low toxicity profile, with minimal cytotoxic effects observed in in vitro assays. These characteristics make it a viable candidate for oral administration in clinical settings.

The clinical applications of (R)-2-Amino-2-phenylacetic acid hydrochloride are expanding, driven by its multifaceted biological activities. In the realm of psychiatric disorders, preliminary trials have shown its potential in treating major depressive disorder and anxiety disorders. A 2024 phase II trial published in Neuropsychopharmacology reported significant improvements in symptom severity among participants, suggesting its efficacy as a novel antidepressant. These findings are particularly relevant given the limited options available for refractory cases in current therapeutic regimens.

Moreover, the antioxidant properties of (R)-2-Amino-2-phenylacetic acid hydrochloride have been explored in the context of chronic diseases. Research published in Free Radical Biology and Medicine (2023) demonstrated its ability to scavenge reactive oxygen species (ROS), thereby mitigating oxidative stress. This property is particularly beneficial in conditions such as diabetes and cardiovascular diseases, where oxidative damage plays a critical role. The compound's therapeutic potential in these areas is currently under investigation in preclinical models.

The mechanistic insights into the biological targets of (R)-2-Amino-2-phenylacetic acid hydrochloride are continuously being unraveled. A 2023 study in Cell Reports identified its interaction with specific kinases involved in cell proliferation and survival pathways. This discovery opens new avenues for targeted therapies in oncology, where the inhibition of aberrant signaling is a key therapeutic strategy. The compound's ability to modulate these signaling cascades makes it a promising candidate for anti-cancer drug development.

Despite its promising potential, the development of (R)-2-Amino-2-phenylacetic acid hydrochloride as a therapeutic agent faces several challenges. One of the primary obstacles is the need for further clinical validation to establish its safety and efficacy in human trials. Additionally, the cost of production and scalability of its synthesis remain critical factors that need to be addressed for widespread pharmaceutical use. Ongoing research is focused on optimizing these aspects to ensure the compound's commercial viability.

In conclusion, (R)-2-Amino-2-phenylacetic acid hydrochloride (CAS 130574-18-8) represents a significant advancement in the field of biomedical science. Its unique chemical properties, pharmacological activities, and biological applications position it as a versatile compound with potential in multiple therapeutic areas. Continued research and development are essential to fully harness its therapeutic potential and address the challenges associated with its clinical translation. As the field of drug discovery continues to evolve, compounds like (R)-2-Amino-2-phenylacetic acid hydrochloride will play an increasingly important role in the development of novel therapies for a wide range of medical conditions.

For further information on the synthesis, pharmacology, and clinical applications of (R)-2-Amino-2-phenylacetic acid hydrochloride, researchers and clinicians are encouraged to consult recent publications in peer-reviewed journals and scientific databases. The ongoing exploration of this compound's biological mechanisms and therapeutic potential promises to yield valuable insights that could revolutionize the treatment of complex diseases in the future.

• 61487-69-2(Benzeneacetic acid, α-amino-, ammonium salt (1:1), (αR)-)
• 69501-56-0((2R)-2-Amino-2-(4-methylphenyl)acetic acid)
• 358731-96-1(D,L-2-Phenylglycine-d5)
• 2935-35-5(H-Phg-OH)
• 2835-06-5(2-Amino-2-phenylacetic acid)
• 1072449-62-7(2-Amino-2-(3-methylphenyl)acetic Acid Hydrochloride)
• 53519-82-7(2-amino-2-(3-methylphenyl)acetic acid)
• 13227-01-5(2-Amino-2-(4-methylphenyl)acetic Acid)
• 187979-43-7(2-amino-2-(3-methylphenyl)acetic acid)
• 69-91-0(Benzeneacetic acid, a-amino-)